RIZATRIPTAN TW rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

rizatriptan benzoate

Lyfjaform:

Tablet, orally disintegrating

Samsetning:

Excipient Ingredients: mannitol; crospovidone; sodium stearylfumarate; ethylcellulose; colloidal anhydrous silica; silicon dioxide; hypromellose; acesulfame potassium; Flavour

Stjórnsýsluleið:

Sublingual

Einingar í pakka:

3, 2, 6

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

for acute treatment of migraine attacks with or without aura.

Vörulýsing:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Licence status A

Leyfisdagur:

2015-03-20